Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 14, 2007 - Issue 3
71
Views
8
CrossRef citations to date
0
Altmetric
Original

Secondary amyloidosis in a needle phobic intra-venous drug user

, &
Pages 255-258 | Published online: 06 Jul 2009
 

Abstract

A case of acute-on-chronic renal failure is presented that is the sequela of secondary (AA) amyloidosis in a hepatitis positive intravenous drug user (IVDU) with chronic venous ulceration. The importance of groin examination is stressed when upper limb veins in a suspected IVDU are normal. Recent epidemiological data is discussed that suggests geographical location and the subcutaneous (SC) route of drug administration are both contributing factors to the development of AA amyloidosis and not chronic infection with HIV, HBV or HCV.

Abbreviations
AA=

secondary amyloidosis

DVT=

deep vein thrombosis

HBV=

hepatitis B virus

HBVcAb=

hepatitis B virus core antibody

HBVsAb=

hepatitis B virus surface antibody

HBVsAg=

hepatitis B virus surface antigen

HCV=

hepatitis C virus

HCVAb=

hepatitis C virus antibody

HIV=

human immunodeficiency virus

HIVAb=

human immunodeficiency virus antibody

IV=

intravenous

IVDU=

intravenous drug user

SC=

subcutaneous

Abbreviations
AA=

secondary amyloidosis

DVT=

deep vein thrombosis

HBV=

hepatitis B virus

HBVcAb=

hepatitis B virus core antibody

HBVsAb=

hepatitis B virus surface antibody

HBVsAg=

hepatitis B virus surface antigen

HCV=

hepatitis C virus

HCVAb=

hepatitis C virus antibody

HIV=

human immunodeficiency virus

HIVAb=

human immunodeficiency virus antibody

IV=

intravenous

IVDU=

intravenous drug user

SC=

subcutaneous

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.